摘要:
The invention provides novel therapeutic compounds, pharmaceutical compositions comprising these compounds, and methods for using these compounds and compositions to treat diseases and disorders such as cancer.
摘要:
The invention relates to compounds of Formulae I-III: and therapeutic uses thereof, wherein A is chosen from a substituted or unsubstituted aryl, heteroaryl, heterocyclic, or carbocyclic group; B is chosen from a substituted or unsubstituted piperidine, homopiperidine, piperazine, pyrrolidine or azetidine group; R1 is chosen from hydro, alkyl, aryl, heteroaryl, amino, or halo; and L1, L2, are as defined herein.
摘要翻译:本发明涉及式I-III的化合物及其治疗用途,其中A选自取代或未取代的芳基,杂芳基,杂环或碳环基团; B选自取代或未取代的哌啶,高哌啶,哌嗪,吡咯烷或氮杂环丁烷基; R 1选自氢,烷基,芳基,杂芳基,氨基或卤素; 和L1,L2如本文所定义。
摘要:
The invention provides novel therapeutic compounds, pharmaceutical compositions comprising these compounds, and methods for using these compounds and compositions to treat diseases and disorders, such as cancer.
摘要:
The invention relates to compounds of Formula I and their therapeutic uses, wherein substituent A is chosen from a substituted or unsubstituted aryl, heteroaryl, heterocyclic, or carboxylic group, B is chosen from a substituted or unsubstituted piperidine, homopiperidine, piperazine, pyrrolidine or azetidine group, R1 is chosen from hydro, alkyl, aryl, heteroaryl amino and halo, and L1 and L2 are as defined in the specification.
摘要:
An organic light emitting display device comprising: a data driver supplying data signals to data output lines; a scan driver supplying scan signals sequentially to scan output lines; a light emitting control line driver supplying light emitting control signals to light emitting control output lines; and a pixel unit including a plurality of pixels connected to the output lines of each driver, at least one driver having a buffer circuit disposed at each output line. Each buffer circuit comprises a transistor having a gate layer, source and drain layers and a metal layer for shielding Electro-Static Discharge (ESD), wherein the metal layer is formed over the gate layer when the gate layer is overlapped by one of the source or a drain electrodes, or the metal layer is formed to not overlap the gate layer when the gate layer is not overlapped by the source or a drain electrodes.
摘要:
The invention relates to compounds, pharmaceutical compositions and methods useful for treating cancer, systemic or chronic inflammation, rheumatoid arthritis, diabetes, obesity, T-cell mediated autoimmune disease, ischemia, and other complications associated with these diseases and disorders.
摘要:
Apparatuses of a base station and terminal in a wireless communication system and their operating methods are provided. An operating method of a base station in a broadband wireless communication system includes determining whether to relocate at least one persistently allocated resource, when it is determined to relocate the at least one persistently allocated resource, relocating the at least one persistently allocated resource, generating a resource relocation Information Element (IE) indicative of the resource relocation using an offset of a Resource Block (RB), and transmitting the resource relocation IE.
摘要:
An apparatus and method manage an operation mode of a mobile station in a wireless communication system. Here, a method for managing an operation mode of a Mobile Station (MS) that uses a service of a strict interactive response time in a Base Station (BS) of a wireless communication system includes determining a supportable operation mode of the MS considering at least one of a service type of the MS, an interactive response time required condition of the service, and a user profile of the MS, and sending the MS a control message including the supportable operation mode of the MS.